Ilumya Prices, Coupons and Patient Assistance Programs
Ilumya (tildrakizumab) is a member of the interleukin inhibitors drug class and is commonly used for Plaque Psoriasis, and Psoriasis.
Ilumya Prices
The cost for Ilumya subcutaneous solution (100 mg/mL) is around $16,318 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Ilumya price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Subcutaneous Solution
Quantity | Per unit | Price |
---|---|---|
1 milliliter | $16,317.73 | $16,317.73 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ilumya Coupons and Rebates
Ilumya offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Ilumya Copay Program: Eligible commercially insured patients may pay no more than $5 per dose; maximum benefit of $16,000 per year; for additional information contact the program at 855-445-8692.
- Applies to:
- Ilumya
- Number of uses:
- Per prescription per year
Form more information phone: 855-445-8692 or Visit website
Ilumya Early Access Program: Eligible commercially insured patients whose coverage has been delayed or denied may be able to receive medication free for up to 2 years; for additional information contact the program at 855-445-8692.
- Applies to:
- Ilumya
- Number of uses:
- Temporary Assistance
Form more information phone: 855-445-8692 or Visit website
Patient Assistance Programs for Ilumya
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit Website
Provider: Ilumya Support Patient Assistance Program
Elligibility requirements:- Uninsured or Underinsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
More information please phone: 855-445-8692 Visit Website
More about Ilumya (tildrakizumab)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (4)
- Patient tips
- Compare alternatives
- En español
- Drug class: interleukin inhibitors
- FDA approval history